Keyword: Aravive Biologics
Former Aravive Chairman Ray Tabibiazar will serve as senior vice president of corporate development and business strategy at Twist Bioscience.
Aravive will merge with the struggling Versartis and gain access to the Nasdaq
Seattle Genetics names Keytruda developer as CMO and Aravive CEO Stephen Eck leaves to join Immatics.
Former Astellas and Aravive executive Stephen Eck, M.D., Ph.D., has jumped ship to Immatics US as its new chief medical officer.